ScienceDaily — 2009 may well be remembered for its scandal-ridden headlines, from admissions of extramarital affairs by governors and senators, to corporate executives flying private jets while cutting employee benefits, and most recently, to a mysterious early morning car crash in Florida. The past year has been marked by a series of moral transgressions by [...]

(CNN) — House Democrats are signaling that a final health care bill will drop the government-run public health insurance option favored by liberals but rejected by conservatives from both parties.
A House-Senate conference committee will begin negotiations next month on merging health care bills passed by the Democratic majorities in each chamber. However, voting in both [...]

BEI launched its new bio-pharmaceutical ethics initiative, The World Council for Ethical Standards, with the aim of empowering a measurable commitment to excellence in ethics and person-centered decision-making and innovation across the healthcare supply chain.  Initial focus is on the biotechnology and pharmaceutical industries and companies.
The inaugural World Council meeting was held November 19, 2009 and included executives from Merck, Pfizer, Mannkind, [...]

The Biotechnology Industry Organization (BIO) selected Bioethics International (BEI) to direct the ethics panel for its 2010 BIO International Convention in Chicago.
The BIO InternationalConvention is the largest global event for the biotechnology industry attracting the biggest names in biotech. It showcases the many ways the biotechnology and life science industries work together to help heal, fuel, [...]

Buried in the giant health care bills in Congress is a multibillion-dollar bonanza for Silicon Valley’s biotechnology and venture capital industries, sponsored by Rep. Anna Eshoo, a Palo Alto Democrat.  The provision would grant “biologic” drugs, a new class of drugs based on gene splicing and grown in living cells, 12 years of protection from [...]

The Obama administration has begun approving new lines of human embryonic stem cells that are eligible for federally funded experiments, opening the way for millions of taxpayer dollars to be used to conduct research that was put off-limits by President George W. Bush.
Launching a dramatic expansion of government support for one of the most promising [...]